Switching from Gilenya to Lemtrada could trigger MS activity
According to research, switching treatments from Gilenya (fingolimod) to Lemtrada (alemtuzumab) can trigger significant and unexpected disease activity in MS patients...Read more - http://www.ms-uk.org/switching-gilenya- ... ity-070217
Switching from Gilenya to Lemtrada could trigger MS activity
Switching from Gilenya to Lemtrada could trigger MS activity
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 2 Replies
- 1496 Views
-
Last post by jimmylegs
Sat Nov 17, 2018 2:50 pm
-
-
Cervical Intervertebral Disc Displacement in Multiple Sclerosis Patients: A Possible Trigger?
by frodo » Mon Jul 08, 2019 11:22 pm » in General Discussion - 2 Replies
- 363 Views
-
Last post by Taurus
Tue Jul 30, 2019 11:22 pm
-
-
- 0 Replies
- 308 Views
-
Last post by Petr75
Sat Nov 09, 2019 11:26 am
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in General Discussion - 0 Replies
- 1542 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
-
Lemtrada (alemtuzumab) FDA issues risk of stroke warning
by Scott1 » Thu Nov 29, 2018 8:20 pm » in Campath (Lemtrada, Alemtuzumab) - 0 Replies
- 3708 Views
-
Last post by Scott1
Thu Nov 29, 2018 8:20 pm
-
-
-
Fish oil normalizes membrane fluidity and mitochondrial ATPase activity in RRMS
by NHE » Thu Jan 30, 2020 3:31 am » in Natural Approach - 0 Replies
- 6292 Views
-
Last post by NHE
Thu Jan 30, 2020 3:31 am
-
-
- 0 Replies
- 443 Views
-
Last post by Scott1
Mon Jul 29, 2019 11:47 pm
-
- 5 Replies
- 1852 Views
-
Last post by NHE
Mon Mar 18, 2019 10:09 pm
-
- 4 Replies
- 1670 Views
-
Last post by Zyklon
Thu Nov 22, 2018 11:59 am
